Author Archives: Forest Ray PhD

FAST Supports UPenn Research Into microRNA as Angelman Therapy

The Foundation for Angelman Syndrome Therapeutics (FAST) has opened a program supporting new research into treating Angelman syndrome by using microRNA (miRNA) to boost UBE3A protein levels. FAST will collaborate with the Gene Therapy Program at the University of Pennsylvania (UPenn) to design this potential therapy, the organization…

Healx Becomes FAST Partner to Repurpose Medicines for Angelman

Healx and the Foundation for Angelman Syndrome Therapeutics (FAST) are partnering to identify new therapies for Angelman syndrome from among already-approved and available medications, according to a company press release. Finding new uses for old medications — a process called drug repositioning or repurposing —…